Inventor · disambiguated record
David Volkin
Also filed as: VOLKIN DAVID · VOLKIN DAVID B
14 granted patents·9 pending applications·475 citations·filing 1992–2022
94Inventor score
Top patents by PatentIndex Score
23 records- 0194US7456009B2Adenovirus formulationsMERCK & CO INC·Filed 2005·Granted Nov 25, 2008·27 cites·26 claims
- 0293US6251678B1Human papillomavirus vaccine formulationsMERCK & CO INC·Filed 2000·Granted Jun 26, 2001·87 cites·14 claims
- 0392US6616931B1Rotavirus vaccine formulationsMERCK & CO INC·Filed 2000·Granted Sep 9, 2003·47 cites·17 claims
- 0489US6245568B1Human papilloma virus vaccine with disassembled and reassembled virus-like particlesMERCK & CO INC·Filed 2000·Granted Jun 12, 2001·41 cites·17 claims
- 0587US7927870B2DNA vaccine formulationsMERCK SHARP & DOHME·Filed 2006·Granted Apr 19, 2011·7 cites·14 claims
- 0682US5932223ARotavirus vaccine formulationsMERCK & CO INC·Filed 1997·Granted Aug 3, 1999·59 cites·14 claims
- 0777US6358744B1Stabilized human papillomavirus formulationsMERCK & CO INC·Filed 2000·Granted Mar 19, 2002·8 cites·15 claims
- 0877US6210683B1Stabilizers containing recombinant human serum albumin for live virus vaccinesMERCK & CO INC·Filed 1998·Granted Apr 3, 2001·50 cites·19 claims
- 0976US6290967B1Stabilizers for lyophilized vaccinesMERCK & CO INC·Filed 1998·Granted Sep 18, 2001·43 cites·6 claims
- 1073US7351415B2Adenovirus formulationsMERCK & CO INC·Filed 2004·Granted Apr 1, 2008·5 cites·37 claims
- 1165US6051238AStabilizers for lyophilized mumps vaccinesMERCK & CO INC·Filed 1997·Granted Apr 18, 2000·30 cites·18 claims
- 1262US5348941AStabilizers for fibroblast growth factorsMERCK & CO INC·Filed 1992·Granted Sep 20, 1994·32 cites·1 claims
- 1361US2004138165A1DNA vaccine formulationsMERCK & CO INC·Filed 2003·Application pending·0 cites
- 1460US6403098B1Rotavirus vaccine formulationsMERCK & CO INC·Filed 1999·Granted Jun 11, 2002·22 cites·13 claims
- 1558US2009181027A1Anti-IL-12/23p40 Antibodies, Epitopes, Formulations, Compositions, Methods and UsesDAL MONTE PAUL·Filed 2008·Application pending·0 cites
- 1656US6387695B1DNA pharmaceutical formulations comprising citrate or triethanolamine and combinations thereofMERCK & CO INC·Filed 1998·Granted May 14, 2002·17 cites·20 claims
- 1755US2002156037A1DNA vaccine formulationsMERCK & CO INC·Filed 2001·Application pending·0 cites
- 1853US2023040065A1Manufacturing Methods for Producing Anti-TNF Antibody CompositionsJANSSEN BIOTECH INC·Filed 2022·Application pending·0 cites
- 1952US2002041884A1Adenovirus formulationsFiled 2001·Application pending·0 cites
- 2052US2004242522A1Polynucleotide vaccine formulationsFiled 2004·Application pending·0 cites
- 2146US2004033239A1Adenovirus formulationsFiled 2001·Application pending·0 cites
- 2246US2002045594A1Polynucleotide vaccine formulationsMERCK & CO INC·Filed 2001·Application pending·0 cites
- 2343US2001021385A1Human papillomavirus vaccine with disassembled and reassembled virus-like particlesFiled 2001·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when David Volkin files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →